Results 131 to 140 of about 1,649 (190)

Differences in Clinical Outcomes Among Patients With Mold Fungemia. [PDF]

Open Forum Infect Dis
Stewart AG, Laupland KB, Edwards F, Chen SCA, Slavin MA.   +4 more
europepmc   +1 more source

The looming threat of invasive fungal infections in heart transplant recipients: Will it be the last of us. [PDF]

JHLT Open
Lowe A, King ST, Hand J.
europepmc   +1 more source

Immunoproteomic Identification of <i>Scedosporium boydii</i> Antigens with Potential Diagnostic Interest in Cystic Fibrosis Patients. [PDF]

J Proteome Res
Martin-Souto L, Abio-Dorronsoro L, Areitio M, Aparicio-Fernandez L, Rodriguez-Erenaga O, Martin-Gomez MT, Antoran A, Rementeria A, Buldain I, Ramirez-Garcia A.   +9 more
europepmc   +1 more source

Species distribution, antifungal susceptibility, and clinical profiles of patients with osteoarticular fungal Infections: A retrospective study. [PDF]

New Microbes New Infect
Liu J, Zhang K, Yu R, Han H, Zhao P.
europepmc   +1 more source

Non-<i>Aspergillus</i> molds. [PDF]

JHLT Open
Eichenberger EM, Mendoza MA, Baddley JW.
europepmc   +1 more source

Accuracy and actionability of mold PCR on bronchoalveolar lavage fluid for diagnosis of invasive mold disease. [PDF]

J Clin Microbiol
Demir KK, Anderson G, Budvytiene I, Banaei N.   +3 more
europepmc   +1 more source

Antifungal Minimal Inhibitory Concentrations of Mold Isolates from Patients with Cancer; Single-Center Experience, 2018-2023. [PDF]

J Fungi (Basel)
Mahmud HA, Dadwal SS, She RC.
europepmc   +1 more source

Repurposing antiviral agents against mucormycosis. [PDF]

PLoS One
Khan AA, AlKashef NM, Seleem MN.
europepmc   +1 more source

Microbe Profile: <i>Streptomyces formicae</i> KY5: an ANT-ibiotic factory. [PDF]

Microbiology (Reading)
Devine R, Noble K, Wilkinson B, Hutchings M.   +3 more
europepmc   +1 more source